Your browser doesn't support javascript.
loading
Author Correction: GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer.
Long, Yao; Guo, Jiaxing; Chen, Jielin; Sun, Jingyue; Wang, Haiyan; Peng, Xin; Wang, Zuli; Lai, WeiWei; Liu, Na; Shu, Long; Chen, Ling; Shi, Ying; Xiao, Desheng; Liu, Shuang; Tao, Yongguang.
Afiliação
  • Long Y; Department of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion(Ministry of Education), Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China.
  • Guo J; NHC Key Laboratory of Carcinogenesis of Ministry of Health (Central South University), Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan, 410078, China.
  • Chen J; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Sun J; Hunan Key Laboratory of Tumor Models and Individualized Medicine, Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, China.
  • Wang H; Department of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion(Ministry of Education), Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China.
  • Peng X; NHC Key Laboratory of Carcinogenesis of Ministry of Health (Central South University), Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan, 410078, China.
  • Wang Z; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Lai W; Hunan Key Laboratory of Tumor Models and Individualized Medicine, Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, China.
  • Liu N; Department of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion(Ministry of Education), Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China.
  • Shu L; NHC Key Laboratory of Carcinogenesis of Ministry of Health (Central South University), Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan, 410078, China.
  • Chen L; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Shi Y; Hunan Key Laboratory of Tumor Models and Individualized Medicine, Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, China.
  • Xiao D; Department of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion(Ministry of Education), Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China.
  • Liu S; NHC Key Laboratory of Carcinogenesis of Ministry of Health (Central South University), Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan, 410078, China.
  • Tao Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Signal Transduct Target Ther ; 8(1): 259, 2023 Jun 30.
Article em En | MEDLINE | ID: mdl-37391407
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China